Rankings
▼
Calendar
ELAN FY 2019 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
FY 2019 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$3.1B
+0.1% YoY
Gross Profit
$1.4B
45.6% margin
Operating Income
$370M
12.0% margin
Net Income
$68M
2.2% margin
EPS (Diluted)
$0.18
Cash Flow
Operating Cash Flow
$224M
Free Cash Flow
$27M
Stock-Based Comp.
$49M
Balance Sheet
Total Assets
$9.0B
Total Liabilities
$3.4B
Stockholders' Equity
$5.5B
Cash & Equivalents
$334M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.1B
$3.1B
+0.1%
Gross Profit
$1.4B
$1.3B
+8.1%
Operating Income
$370M
$314M
+17.9%
Net Income
$68M
$87M
-21.5%
← Q4 2018
All Quarters
Q1 2019 →